Clinical characteristics, incidence, and risk factors of HIV-Related hodgkin lymphoma in the era of combination antiretroviral therapy

AIDS Patient Care and STDs

Volumn 27, Issue 5, 2013, Pages 259-265

  Gotti, Daria ^a   Danesi, Marta ^a   Calabresi, Alessandra ^a   Ferraresi, Alice ^a   Albini, Laura ^a   Donato, Francesco ^b   Castelli, Francesco ^a   Scalzini, Alfredo ^c   Quiros Roldan, Eugenia ^c,d,e  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Spedali Civili of Brescia ^*  (Italy)

^d Brescia HIV Study Cancer Group: S Casari   (Italy)

^e Brescia Local Health Authority   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIV RELATED HODGKIN LYMPHOMA; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; STANDARDIZED INCIDENCE RATIO;

ADULT; ANTI-RETROVIRAL AGENTS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; ITALY; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; POISSON DISTRIBUTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84877631138     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0424     Document Type: Article

References (31)

1. Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011;103:753-762.
2. Bohlius J, Schmidlin K, Boue F, et al. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: Incidence and evolution of CD4( + ) T-cell lymphocytes. Blood 2011;117:6100-6108.
3. Seaberg EC, Wiley D,Martinez-Maza O, et al. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 2010;116:5507-5516.
4. Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003; 89:94-100. (Pubitemid 36897942)
5. Long JL, Engels EA, Moore RD, Gebo KA. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS 2008;22:489-496. (Pubitemid 351317290)
6. Clifford GM, Rickenbach M, Lise M, et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood 2009;113:5737-5742.
7. Polesel J, Franceschi S, Suligoi B, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010;127:1437-1445.
8. Lanoy E, Rosenberg PS, Fily F, et al. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood 2011;118:44-49.
9. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009;27: 884-890.
10. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006;108:3786-3791. (Pubitemid 44864560)
11. Vaccher E, Spina M, Tirelli U. Clinical aspects and management of Hodgkin's disease and other tumours in HIVinfected individuals. Eur J Cancer 2001;37:1306-1315. (Pubitemid 32553775)
12. Carbone A, Gloghini A, Serraino D, Spina M. HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS 2009;4:3-10.
13. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virusassociated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 1997;70:375-382. (Pubitemid 27107262)
14. Montoto S, Shaw K, Okosun J, et al. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemioterapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral era. J Clin Oncol 2012; 30:4111-4116.
15. Dal Maso L, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009;100:840-847.
16. Regione Lombardia/ASL Brescia. Documento di programmazione e coordinamento dei servizi sanitari e socio-sanitari dell'ASL di Brescia per l'anno 2012. Available at: www.aslbrescia. it/media/pdf/2012 (accessed 25 September 2012).
17. Centro operativo AIDS. Aggiornamento delle nuove diagnosi di infezione da HIV al 31 dicembre 2009 e dei casi di AIDS in Italia al 31 dicembre 2010. Supplemento del notiziario dell'Istituto Superiore di Sanità . 2011;24:1-32.
18. Master Cohort. Available at: www.mastercohort.it/il-pro getto/presentazione-della-coorte/(accessed 2 Dec 2012).
19. Prosperi MC, Cozzi-Lepri A, Castagna A, et al. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: Evidence from a large Italian cohort study. Clin Infect Dis 2010;50:1316-1321.
20. Calabresi A, Ferraresi A, Limina RM, et al. A populationbased database to study malignancies in HIV-infected patients in the Local Agency of Brescia between 1999 and 2009. Epidemiol Prev 2012. [Epub ahead of print].
21. International Classification of Disease (ICD)-10 version.World HealthOrganization, 2010.Available at: http://www.who.int/classifications/icd/ en/(accessed 28 Nov 2012).
22. Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early-and late-HAART periods: The Swiss HIV Cohort Study. Br J Cancer 2010;103: 416-422.
23. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-194. (Pubitemid 351705208)
24. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148:728-736. (Pubitemid 351717418)
25. Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Int Med 2010;153:452-460.
26. Hentrich M, Berger M, Wyen C, et al. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: Results of a prospective multicenter study. J Clin Oncol 2012;30:4117-4123
27. Petoumenos K, van Leuwen M, Vajdic C, et al. Cancer, immunodeficiency and antiretroviral treatment: Results from the Australian HIV Observational Database (AHOD). HIV Med 2013;14:77-84.
28. Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N. Characteristics of non-AIDS-defining malignancies in the HAART era: A clinico-epidemiological study. J Intl AIDS Soc 2011;14:16.
29. Vogel M, Friedrich O, Luchters G, et al. Cancer risk in HIVinfected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. Eur J Med Res 2011;16:101-107.
30. Reekie J, Kosa C, Engsig F, et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer 2010;116: 5306-5315.
31. Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, Costagliola D, Clinical Epidemiology Group of the F-ACOc. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): A prospective cohort study. Lancet Oncol 2009;10:1152-1159.